Esteban González Ballerga

Author

Also Known As

E González Ballerga, E. Gonzalez Ballerga, Esteban Ballerga, Esteban G. Ballerga, Esteban Gonzalez Ballerga, Esteban González Ballerga, Esteban González Ballerga

Publications

436

Citations

H-Index

Concepts

All Affiliations

Universidad de Buenos Aires Hospital de Clínicas "José de San Martín"Hospital Nacional Cayetano Heredia Hospital Privado Hospital Muñiz

About

Esteban González Ballerga is an author at Universidad de Buenos Aires specializing in medicine, physiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	50
2	Health Sciences	1	1	21
3	Biochemistry	1	1	21
4	Diabetes	1	1	21
5	Epidemiology	1	1	29

Esteban González Ballerga

Publications

393

Citations

H-Index

Page 1

	Year	Citations
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy José D. Debes, Aaron J. Chan, Domingo Balderramo, Liver International	2017	94
New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans María Eugenia Inzaugarat, Elena De Matteo, Plácida Baz, PLoS ONE	2017	65
Hepatic lipase activity is increased in non‐alcoholic fatty liver disease beyond insulin resistance Verónica Miksztowicz, Diego Lucero, Valeria Zago, Diabetes/Metabolism Research and Reviews	2012	49
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements Gennaro D’Amico, Alexander Zipprich, Càndid Villanueva, Hepatology	2023	44
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission Manuel Mendizábal, Federico Piñero, Ezequiel Ridruejo, Annals of Hepatology	2021	34
Early Age Hepatocellular Carcinoma Associated With Hepatitis B Infection in South America Aaron J. Chan, Domingo Balderramo, Luciana Kikuchi, Clinical Gastroenterology and Hepatology Hepatitis DSouth AmericaHepatologyViral HepatitisHepatitis B Infection	2017	29
Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up Juan Sordá, Esteban González Ballerga, Fernando Javier Barreyro, Alimentary Pharmacology & Therapeutics	2021	26
Alterations in triglyceride rich lipoproteins are related to endothelial dysfunction in metabolic syndrome Diego Lucero, Graciela López, Susana Gorzalczany, Clinical Biochemistry ObesityMetabolic SyndromeMetabolic DisorderCardiovascular DiseaseBiochemistry	2016	21
Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection Manuel Mendizábal, Ezequiel Ridruejo, Federico Piñero, Annals of Hepatology	2021	20
Sublingual microcirculatory alterations in cirrhotic patients Esteban González Ballerga, Mario Omar Pozo, Paolo N. Rubatto Birri, Microcirculation	2018	11

Page 1